Skip to content

Learning Yoga to eNhance Cancer Survivorship

Learning Yoga to eNhance Cancer Survivorship

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04301050
Acronym
LYNC
Enrollment
21
Registered
2020-03-09
Start date
2020-07-27
Completion date
2020-12-31
Last updated
2021-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Young Adult, Cancer Survivor

Brief summary

This study aims to conduct a single-arm pilot test of online yoga classes for young adult cancer survivors (YACS). Study hypotheses are that LYNC will be feasible (enrollment of \> 50% of eligible) and acceptable (75% attendance at all sessions). In addition, analyses of preliminary efficacy outcomes will examine whether participants report potential improvements in psychosocial and physical wellbeing.

Detailed description

This study will recruit YACS (n=30) for an 8-week course (75-minute yoga classes delivered once per week) delivered online via videoconferencing software such as Zoom or Bluejeans. During yoga classes, all participants will be able to see one another, to simulate the group experience of being in an in-person class. Participants will complete patient-reported outcomes of physical and psychosocial wellbeing at baseline (prior to class 1) and post-intervention (after class 8), as well as post-intervention measures of feasibility/acceptability (e.g., ease of accessing online classes, satisfaction with yoga classes, helpfulness of online yoga, barriers/dislikes associated with online yoga). All surveys will be administered via REDCap. In addition, the investigators will compute rates of retention (% of consenting subjects who complete post-intervention assessment) and adherence (# of yoga classes attended).

Interventions

OTHERYoga Intervention

Weekly 75-minute yoga classes.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Age 25-39 * History of cancer diagnosed at age \>18 * \>2 months post-treatment for cancer * Eastern Cooperative Oncology Group (ECOG) performance status (0-2) * Access to internet-connected device with camera and capacity for full-screen display (e.g., laptop or desktop computer; tablet or smart phone with Air Play to full-size monitor)

Exclusion criteria

* Regular use of yoga (i.e., once or more per week) since cancer diagnosis/treatment * Unable to complete forms and yoga classes in English * Adults who are cognitively impaired, pregnant, imprisoned or otherwise detained

Design outcomes

Primary

MeasureTime frameDescription
Feasibility9 monthsEnrollment rate of \> 50% of eligible screened participants
Acceptability8 weeksAttendance rate: \>75% of classes, on average

Secondary

MeasureTime frameDescription
Change in Depression[Baseline, 8 week]As measured by PROMIS SF (Patient Reported Outcomes Measurement Information System Short Form) v1.0 - Depression 4a
Change in Anxiety[Baseline, 8 week]As measured by PROMIS SF v1.0 - Anxiety 4a
Change in Sleep Disturbance[Baseline, 8 week]As measured by PROMIS SF v1.0 - Sleep Disturbance 4a
Change in Fatigue[Baseline, 8 week]As measured by PROMIS SF v1.0 - Fatigue 7a
Change in Health Behaviors[Baseline, 8 week]Health behaviors are measured with a 10-item scale adapted from investigators' prior research. Items allow for calculation of body mass index (based on self-reported height and weight), determination of the amount of physical activity per week, and indicators of diet quality. Items are based on American Cancer Society and National Comprehensive Cancer Network guidelines for health behaviors in cancer survivors.
Change in Pain Interference[Baseline, 8 week]As measured by PROMIS SF v1.0 - Pain Interference 6b
Change in Physical Function[Baseline, 8 week]As measured by PROMIS SF v2.0 - Physical Function 4a PROMIS SF v2.0 - Physical Function 4a
Change in Positive Affect[Baseline, 8 week]As measured by PROMIS SF v1.0 - Positive Affect 15a PROMIS SF v1.0 - Positive Affect 15a
Change in Social Isolation[Baseline, 8 week]As measured by PROMIS SF v2.0 - Social Isolation 8a
Change in Pain Intensity[Baseline, 9 week]As measured by PROMIS Scale v1.0 - Pain Intensity 3a PROMIS SF v1.0 - Fatigue 7a
Change in Interoceptive Awareness[Baseline, 8 week]As measured by a change in the body listening and trusting sub scales of the Multidimensional Assessment of Interoceptive Awareness (Version 2). Scores on this scale range from 0-5, with higher scores indicating greater interoceptive awareness.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026